Skip to content
lifestyle.projectdiaspora.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Transgene S.A.
Transgene Provides Business and Financial Update for Q1 2026
May 6, 2026
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
May 3, 2026
Availability of Transgene’s 2025 Universal Registration Document (URD)
May 3, 2026
←
Previous Page
1
2